Novel complication of nusinersen treatment: Hyponatremia

Creative Commons License

Coban Y., Aslan N., Yildizdas D. , ÖZGÜR HOROZ Ö. , GÜL MERT G.

NEUROLOGY ASIA, cilt.25, ss.85-86, 2020 (SCI İndekslerine Giren Dergi) identifier identifier


Nusinersen is a novel therapy for spinal muscular atrophy (SMA) type 1. Thus, the adverse reactions of the therapy have not been well established. We present here a 5-months old boy with SMA type 1, who developed hyponatremia after a single dose of nursinersen which has been rarely reported previously.